Skip to main content
. 2013 Jul 23;8(7):e69039. doi: 10.1371/journal.pone.0069039

Table 1. Demographic characteristics, clinical features, and allele distributions of study patients.

Total Colon Rectum
Variablesa N (%) N (%) N (%) P
Ageb (y) 58.5±12.5 57.1±12.9 60.4±11.6 0.004c
Sex 0.105d
Male 260 (52.9) 141 (49.8) 119 (57.2)
Female 231 (47.1) 142 (50.2) 89 (42.8)
Family history of cancer 0.961d
No 305 (64.5) 175 (64.6) 130 (64.4)
Yes 168 (35.5) 96 (35.4) 72 (35.6)
Multiplicity 0.029d
No 467 (95.1) 264 (93.3) 203 (97.6)
Yes 24 (4.9) 19 (6.7) 5 (2.4)
Histological differentiation 0.009d
Well 59 (12.1) 38 (13.6) 21 (10.1)
Moderately 382 (78.4) 207 (73.9) 175 (84.5)
Poorly 46 (9.5) 35 (12.5) 11 (5.4)
Carcinoembryonic antigen 0.086d
<5 ng/mL 219 (46.4) 117 (43.0) 102 (51.0)
≥5 ng/mL 253 (53.6) 155 (57.0) 98 (49.0)
TNM stage 0.001d
II 74 (15.1) 56 (19.8) 18 (8.7)
III 267 (54.4) 138 (48.8) 129 (62.0)
IV 150 (30.5) 89 (31.4) 61 (29.3)
GSTM1 0.254d
Null 286 (58.2) 171 (60.4) 115 (55.3)
Present 205 (41.8) 112 (39.6) 93 (44.7)
GSTT1 0.317d
Null 249 (50.7) 149 (52.6) 100 (48.1)
Present 242 (49.3) 134 (47.4) 108 (51.9)
GSTP1 Ile105Val 0.632d
Ile/Ile 336 (68.4) 191 (67.5) 145 (69.7)
Ile/Val 139 (28.3) 81 (28.6) 58 (27.9)
Val/Val 16 (3.3) 11 (3.9) 5 (2.4)
XRCC1 Arg399Gln 0.016d
Arg/Arg 249 (50.7) 159 (56.2) 90 (43.3)
Arg/Gln 212 (43.2) 110 (38.9) 102 (49.0)
Gln/Gln 30 (6.1) 14 (5.0) 16 (7.7)
XRCC3 Thr241Met 0.565e
Thr/Thr 459 (93.5) 263 (92.9) 196 (94.2)
Thr/Met 32 (6.5) 20 (7.1) 12 (5.8)
Met/Met 0 (0.0) 0 (0.0) 0 (0.0)
XPD Lys751Gln 0.327e
Lys/Lys 404 (82.3) 234 (82.7) 170 (81.7)
Lys/Gln 84 (17.1) 46 (16.2) 38 (18.3)
Gln/Gln 3 (0.6) 3 (1.1) 0 (0.0)
a

Sum may not be equal to the total number (N) because of missing data.

b

Mean±standard deviation.

c

Student t-test.

d

Chi-squared test.

e

Fisher exact test.

TNM: tumor-node-metastasis.